PubRank

M Delaunay

Author PubWeight™ 27.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma. Lancet 1998 3.84
2 Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol 1999 2.34
3 Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice. Br J Cancer 1999 1.96
4 Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000 1.29
5 Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood 2000 1.27
6 Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer 2000 0.98
7 Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée. Eur J Cancer 1998 0.91
8 [Eccrine porocarcinoma: a highly malignant tumor with a poor prognosis]. Ann Dermatol Venereol 2008 0.91
9 Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996 0.88
10 White blood cell count: a prognostic factor and possible subset indicator of optimal treatment with low-dose adjuvant interferon in primary melanoma. Clin Cancer Res 2000 0.87
11 Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients. Dermatology 2001 0.86
12 The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol 1999 0.86
13 Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study Group. Cancer Chemother Pharmacol 1990 0.85
14 Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas. Blood 1999 0.84
15 Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial. Br J Cancer 2001 0.83
16 Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma. Eur J Cancer 2001 0.83
17 Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas. Am J Surg Pathol 2003 0.81
18 Rapidly lethal dermatomyositis associated with metastatic melanoma. J Eur Acad Dermatol Venereol 2008 0.81
19 Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas. J Invest Dermatol 2001 0.81
20 Pilotropic cutaneous T-cell lymphoma without mucinosis. A variant of mycosis fungoides? French Study Group of Cutaneous Lymphomas. Arch Dermatol 1996 0.80
21 A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas. Arch Dermatol 1999 0.79
22 Neoadjuvant chemotherapy: a new criterion for selection of candidate patients for surgery of low tumour burden metastases from malignant melanoma? Br J Dermatol 2010 0.79
23 Cardiomyopathy after acute myocardial infarction after therapy with interleukin-2 and tumour infiltrating lymphocytes. Eur J Cancer 1992 0.78
24 Evaluation of a 1-h exposure time to mechlorethamine in patients undergoing topical treatment. Br J Dermatol 2002 0.78
25 [Treatment of metastatic melanoma with dacarbazine recombinant interferon alfa 2A combination: results of multicentric study]. Bull Cancer 1990 0.77
26 In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates. Int J Cancer 2000 0.77
27 [Care at home. The actors in home hospitalization]. Soins 1996 0.75
28 [Malignant melanoma occurring on a burn scar]. Ann Dermatol Venereol 1991 0.75
29 [Eulogy of the present]. Ann Dermatol Venereol 1998 0.75
30 [Paradoxical menstruation and resistant ascites due to granulosa cell tumor in postmenopause. Value of the cytogenetic study of the ascitic fluid]. Sem Hop 1973 0.75
31 [Tuberculous brain abscess]. Presse Med 1991 0.75
32 [Trichoblastoma of the scalp]. Ann Dermatol Venereol 2005 0.75
33 [Purplish nodules on the lymphedema. Stewart-Treves syndrome]. Ann Dermatol Venereol 2000 0.75
34 [Management of lymph nodes in head and neck melanoma: a retrospective study of 25 cases]. Rev Stomatol Chir Maxillofac 2007 0.75
35 [Melanoma-associated retinopathy. Apropos of a case and review of the literature]. Bull Cancer 1996 0.75
36 [Argon laser photocoagulation treatment of macular venule occlusions]. Bull Mem Soc Fr Ophtalmol 1978 0.75
37 [Cutaneous CD8+ squamous T-cell bullous lymphoma]. Ann Dermatol Venereol 2005 0.75
38 Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up. Br J Dermatol 2005 0.75
39 Absolute measurements and theoretical calculations of photoionization cross sections along the isonuclear sequence of multiply charged barium ions. Phys Rev Lett 2001 0.75
40 Erythema gyratum repens-like eruption in mycosis fungoides: is dermatophyte superinfection underdiagnosed in cutaneous T-cell lymphomas? J Eur Acad Dermatol Venereol 2008 0.75
41 [Vascular complications of diabetes]. Bord Med 1972 0.75
42 [Lepromatous leprosy in a Portugese woman working in a dairy]. Bord Med 1972 0.75
43 [4 years of use of a linear accelerator in dermatology]. Ann Dermatol Syphiligr (Paris) 1975 0.75